Evidence map›Paper›PMID 37625511›Full record

ArticleAmerican journal of ophthalmology2023

Development and Validation of the Low Vision Severely Constricted Peripheral Eyesight (LV-SCOPE) Questionnaire.

Joshua R Ehrlich, Chris Andrews, Abigail Kumagai, Jenna Goldstein, K Thiran Jayasundera, Joan Stelmack, Robert Massof, Paul P Lee, Noelle E Carlozzi

Abstract read
In one paragraph

Article in American journal of ophthalmology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Exploring the Writing and Typing Needs of Older Adults with Acquired Vision Loss: A Qualitative Study of Challenges and Adaptive Strategies.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Joshua R EhrlichFrom the Department of Ophthalmology and Visual Sciences (J.R.E., C.A., K.T.J., P.P.L.), University of Michigan, Ann Arbor, Michigan, USA; Institute for Social Research (J.R.E.), University of Michigan, Ann Arbor, Michigan, USA. Electronic address: joshre@umich.edu.
Chris AndrewsFrom the Department of Ophthalmology and Visual Sciences (J.R.E., C.A., K.T.J., P.P.L.), University of Michigan, Ann Arbor, Michigan, USA.
Abigail KumagaiWayne State University School of Medicine (A.K.), Detroit, Michigan, USA.
Jenna GoldsteinUniversity of Michigan Medical School (J.G.), Ann Arbor, Michigan, USA.
K Thiran JayasunderaFrom the Department of Ophthalmology and Visual Sciences (J.R.E., C.A., K.T.J., P.P.L.), University of Michigan, Ann Arbor, Michigan, USA.
Joan StelmackDepartment of Ophthalmology and Visual Sciences (J.S.), University of Illinois, Chicago, Illinois, USA.
Robert MassofWilmer Eye Institute (R.M.), Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Paul P LeeFrom the Department of Ophthalmology and Visual Sciences (J.R.E., C.A., K.T.J., P.P.L.), University of Michigan, Ann Arbor, Michigan, USA.
Noelle E CarlozziDepartment of Physical Medicine and Rehabilitation (N.E.C.), University of Michigan, Ann Arbor, Michigan, USA; Center for Clinical Outcomes Development and Application (N.E.C.), University of Michigan, Ann Arbor, Michigan, USA.

Funding

Addressing Low Vision due to Severe Peripheral Field Loss: Development and Validation of a Patient-Centered Outcome MeasureK23EY027848 · NEI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI EHRLICH, JOSHUA ROBERT · 2017 to 2021
$1.2M
NEI NIH HHS K23 EY027848
6 · The paper itself

Abstract

purposeTo develop and validate a novel patient-reported outcome (PRO) measure to assess vision-related functioning in individuals with severe peripheral field loss (PFL).

designProspective outcome measure development/validation study.

methodsA 127-item questionnaire was developed based on a prior qualitative interview study. A total of 116 participants with severe PFL due to retinitis pigmentosa (RP) or glaucoma were recruited at the Kellogg Eye Center and completed the Likert-scaled telephone-administered questionnaire. Included participants had a horizontal extent of their visual field <20 degrees (RP) or a mixed or generalized stage 4 to 5 defect using the Enhanced Glaucoma Staging System (glaucoma) in the better seeing eye (or in 1 eye if the fellow eye visual acuity was <20/200). Response data were analyzed using exploratory factor analysis and Rasch modeling. Poorly functioning items were eliminated, confirmatory factor analysis was used to ensure scale unidimensionality, and the model was refit to produce the final instrument.

resultsThe final Low Vision Severely Constricted Peripheral Eyesight (LV-SCOPE) Questionnaire contains 53 items across 6 domains: mobility, object localization, object recognition, reading, social functioning, and technology. There were 74 items removed because of high missingness, poor factor loadings, low internal consistency, high local dependency, low item information, item redundancy, or differential item functioning. Using Rasch item calibrations, person ability scores could be calculated for each of the 6 unidimensional LV-SCOPE domains with good test-retest stability.

conclusionsThe LV-SCOPE Questionnaire provides a valid and reliable measure of vision-related functioning across 6 key domains relevant to individuals with severe PFL. Findings support the clinical utility of this psychometrically valid instrument.

Indexed as

GlaucomaRetinitis PigmentosaVision, LowHumansProspective StudiesPsychometricsQuality of LifeReproducibility of ResultsSurveys and Questionnaires

Identifiers

PMID37625511
PMCPMC10841199

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.